Monthly Archives: September 2010

The U.S. Pharmacopeia – What is it? What Does it Do?

Posted on September 20, 2010 by Mark Senak

One of the most frequent searches I see that people perform when coming to Eye on FDA is this – "Are Canadian Drugs Safe"?  And safety, in this day and age, is the name of the game.   As I've … Continue reading →

Posted in Podcast, Tutorial | Comments Off on The U.S. Pharmacopeia – What is it? What Does it Do?

Weekly Roundup – 09/17/10

Posted on September 17, 2010 by Mark Senak

Well…. Congress is back.  Nuff said on that.   The rest of us are changing gears to autumn.  The summer linens and whites are now stored away in my summer closet.  The white bucks have been put away.  I'm looking … Continue reading →

Posted in Uncategorized | Comments Off on Weekly Roundup – 09/17/10

Lilly Jumps in the Social Media Pool

Posted on September 16, 2010 by Mark Senak

Forgive all the font craziness here – my blogging platform went a little crazy.   Yesterday morning I was on the i-Pad early and was going through my emails and there was a notification that someone called @Lillypad had started … Continue reading →

Posted in Uncategorized | 3 Comments

How Might Mid-term Elections Impact FDA and Pharma?

Posted on September 14, 2010 by Mark Senak

Yesterday the Senate returned to Washington after recess and today the House returns.  Yes, they're baaaaack. That means traffic and congestion has increased and a tidy 12 minute commute turns into a 45 minute snarl. Consider that a metaphor. Today … Continue reading →

Posted in Uncategorized | Comments Off on How Might Mid-term Elections Impact FDA and Pharma?

Weekly Roundup – 09/10/10

Posted on September 10, 2010 by Mark Senak

 For a short week, it seemed like a long one.  And you can tell by my few posts this week, it was a busy one.  Here in Washington, we immediately turned a climate corner with the Labor Day holiday and … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 09/10/10